Adastra's license also will allow it to make and provide psilocybin and psilocin -- hallucinogens a lot more usually referred to as magic mushrooms that develop effects much like LSD. The licensing deal arrives following a radical coverage shift to deal with an opioid overdose crisis that has killed hundreds, by decriminalizing modest quantities